Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
measles rubella vaccine microneedle patch
- Development stage
- Unknown
- Lead developer
- Micron Biomedical
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intradermal
01
Overview
The measles rubella vaccine microneedle patch (MRV-MNP) is a biologic vaccine delivery system being developed by Micron Biomedical in collaboration with the CDC and Georgia Institute of Technology. It consists of a dissolvable microarray patch containing approximately 100 water-soluble microneedles (700 μm in length) formulated with live attenuated measles and rubella viruses. The patch is designed for intradermal delivery, offering a needle-free alternative to traditional subcutaneous injections. A key advantage of the MRV-MNP is its thermostability, maintaining activity at 40°C for up to 28 days, which potentially eliminates the need for cold-chain storage. Clinical trials, including a Phase 1/2 study in infants, toddlers, and adults, have demonstrated safety and high seroconversion rates for both measles and rubella.
- Other names
- measles-rubella vaccine microarray patchMRV-MAP
Beyond the preview
Go deeper on measles rubella vaccine microneedle patch.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on measles rubella vaccine microneedle patch.